Xconomy Boston

Isis Biopolymer Inc. Secures $3,000,000 Series A Financing

  • Feed Type
  • Date
    8/11/2008
  • Company Name
    Isis Biopolymer Inc.
  • Mailing Address
    555 Jefferson Boulevard Warwick, RI 02886
  • Company Description
    Isis Biopolymer, Inc. (“Isis”) is an early stage, Rhode Island-based medical device company. Isis has developed a major advance in intelligent non-invasive drug delivery, the Isis Patch™. The Isis Patch is a personalized, single-use, flexible, ultra-thin, transdermal drug delivery (“TDD”) patch. Isis is pioneering the emerging area of active TDD, which will allow medical professionals, for the first time, to accurately control transdermal drug delivery, ensuring reliable and effective drug administration over an extended period of time.
  • Website
    http://www.isisbiopolymer.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.